Press & Media
GoodOnes™ in the news.
GoodOnes™ is the consumer line of Flore Clinical, founded by Craig Rouskey. Coverage spans probiotics for neurodiversity, microbiome science, and precision gut health. Press inquiries: [email protected]
GoodOnes™ & Flore Clinical — Recent Coverage
The Food Institute
Can Probiotics Improve Autism Symptoms? One Brand Believes So
2024
Globe Newswire
Flore Unveils World's First Line of Probiotics for Neurodiversity
September 2024
Nutraceuticals World
Flore Launches Probiotic Line Formulated for Neurodiversity
September 2024
VitaFoods Insights
Flore Launches World's First Line of Probiotics Targeting Neurodiversity
September 2024
Nutrition Insight
Flore Unveils World's First Probiotics Portfolio for Neurodiversity
September 2024
Nutraceutical Business Review
Flore Debuts First Ever Probiotic Line Catered to Neurodiverse Individuals
2024
NutraIngredients
Flore Clinical Makes Personalized Microbiome Mapping Tech More Accessible to Clinicians
June 2024
BioSpace
Clinical Study Highlights Improvements to Gut Microbiome and Autism Spectrum Disorder Symptoms
2024
KXAN Austin
Flore Clinical Teams Up with Evexia Diagnostics to Reach 20,000 Clinicians
2024
Nutritional Outlook
Personalized-Probiotics Brand Flore Now Offering At-Home Stool Analysis Test
February 2026
Founder Coverage — Craig Rouskey
HAPPI
Wellness Brand Flore Welcomes Craig Rouskey as New CEO
2023
TEDxBellevue
Citizen Science — From Institutions to Community
TEDx Talk
San Diego Patch
Customized Probiotic Brand Flore Welcomes Craig Rouskey as New CEO
2023
Research & Funding History
Press Inquiries
Media contact: [email protected]
For product samples, founder interviews, or clinical data requests, please include your publication and deadline.
Additional resources: About GoodOnes™ · Mechanism Library · Flore Clinical